Efficacy and Safety Comparison Between Intensified Therapy and Conversion Therapy For Advanced HCC After Failure of First-line

NCT07501351 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellulcar Carcinoma

Interventions

DRUG: Intensified Therapy
DRUG: Conversion Therapy

Sponsor

Sun Yat-sen University